Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
495
2.540
 Why?
Thrombolytic Therapy
4
2022
110
1.250
 Why?
Pneumonia, Viral
6
2020
169
1.250
 Why?
Fibrinolytic Agents
4
2022
125
1.240
 Why?
Coronavirus Infections
6
2020
178
1.230
 Why?
Tissue Plasminogen Activator
3
2020
110
1.210
 Why?
Pandemics
8
2020
563
0.810
 Why?
Endovascular Procedures
2
2022
180
0.800
 Why?
Cavernous Sinus
1
2022
16
0.770
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
12
0.770
 Why?
Conflict of Interest
2
2020
25
0.710
 Why?
Embolization, Therapeutic
1
2022
88
0.710
 Why?
Iodine Compounds
1
2020
7
0.690
 Why?
Brain Edema
1
2020
41
0.670
 Why?
Brain Ischemia
4
2022
164
0.630
 Why?
Mucopolysaccharidosis II
1
2018
1
0.620
 Why?
Contrast Media
1
2020
192
0.620
 Why?
Cardiology
1
2020
91
0.620
 Why?
Medicare
1
2020
247
0.610
 Why?
Coronary Angiography
1
2020
359
0.600
 Why?
Physicians
1
2020
232
0.550
 Why?
Hospitalization
6
2022
675
0.480
 Why?
Databases, Factual
3
2020
673
0.410
 Why?
Humans
29
2022
50503
0.400
 Why?
Telemedicine
1
2019
469
0.400
 Why?
Headache
2
2022
75
0.360
 Why?
Aged
10
2021
9741
0.350
 Why?
Time Factors
4
2020
2935
0.340
 Why?
Autoimmune Diseases
2
2020
79
0.330
 Why?
Ischemic Attack, Transient
2
2020
55
0.320
 Why?
Immunosuppressive Agents
2
2020
225
0.310
 Why?
United States
6
2020
4955
0.300
 Why?
Female
16
2021
27081
0.280
 Why?
Male
14
2021
25907
0.260
 Why?
Arkansas
4
2019
1985
0.260
 Why?
Emergency Service, Hospital
2
2020
484
0.250
 Why?
Middle Aged
11
2021
12611
0.240
 Why?
Tomography, X-Ray Computed
2
2020
1164
0.220
 Why?
Triage
2
2021
60
0.220
 Why?
Thrombectomy
2
2020
70
0.210
 Why?
Drug Industry
2
2020
38
0.210
 Why?
Neuroimaging
2
2020
87
0.210
 Why?
Critical Care
2
2021
214
0.190
 Why?
Retrospective Studies
5
2020
6263
0.190
 Why?
Sinus Thrombosis, Intracranial
1
2021
16
0.180
 Why?
Myasthenia Gravis
1
2021
17
0.180
 Why?
Hospitalists
1
2020
11
0.180
 Why?
Intracranial Thrombosis
1
2020
16
0.180
 Why?
Ageusia
1
2020
6
0.180
 Why?
Olfaction Disorders
1
2020
7
0.180
 Why?
Neuromuscular Diseases
1
2020
30
0.180
 Why?
Health Services Misuse
1
2020
13
0.170
 Why?
Osmolar Concentration
1
2020
62
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2020
55
0.170
 Why?
Multiple Sclerosis
1
2020
65
0.170
 Why?
Health Care Sector
1
2020
15
0.170
 Why?
Neurologic Examination
1
2020
76
0.170
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.170
 Why?
Mood Disorders
1
2020
58
0.170
 Why?
Time-to-Treatment
1
2020
73
0.170
 Why?
Patient Transfer
1
2020
95
0.170
 Why?
Venous Thrombosis
1
2020
87
0.170
 Why?
Brain Diseases
1
2020
83
0.170
 Why?
Young Adult
2
2020
4102
0.170
 Why?
Drug-Eluting Stents
1
2020
93
0.160
 Why?
Subarachnoid Hemorrhage
1
2020
65
0.160
 Why?
Suicidal Ideation
1
2020
97
0.160
 Why?
Recombinant Fusion Proteins
1
2010
179
0.160
 Why?
Fabry Disease
1
2019
9
0.160
 Why?
Enzyme Replacement Therapy
1
2019
17
0.160
 Why?
Hospitals
1
2020
173
0.160
 Why?
Nervous System Diseases
1
2020
89
0.160
 Why?
Fluorocarbons
1
2019
58
0.160
 Why?
Tomography Scanners, X-Ray Computed
1
2018
11
0.150
 Why?
Angiogenesis Inhibitors
1
2010
183
0.150
 Why?
Angiography, Digital Subtraction
1
2018
27
0.150
 Why?
Aged, 80 and over
3
2020
3226
0.150
 Why?
Neuroprotective Agents
1
2019
99
0.150
 Why?
Seizures
1
2020
195
0.150
 Why?
Anxiety
1
2020
285
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
138
0.140
 Why?
Pain
1
2020
387
0.140
 Why?
Meningitis
1
2016
25
0.140
 Why?
Referral and Consultation
1
2019
288
0.130
 Why?
Diagnosis, Differential
1
2020
1033
0.130
 Why?
Myocardial Infarction
1
2020
403
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
300
0.130
 Why?
Antibodies, Monoclonal
1
2010
462
0.130
 Why?
Ovarian Neoplasms
1
2010
450
0.130
 Why?
Plasma Cells
1
2016
221
0.120
 Why?
Magnetic Resonance Imaging
2
2020
1548
0.120
 Why?
Adult
5
2020
13577
0.110
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
33
0.100
 Why?
DNA, Complementary
1
2002
133
0.100
 Why?
Adolescent
2
2020
6443
0.100
 Why?
Antineoplastic Agents
1
2010
1172
0.100
 Why?
Mycobacterium tuberculosis
1
2002
266
0.090
 Why?
Treatment Outcome
4
2022
5283
0.080
 Why?
Intubation, Intratracheal
2
2021
119
0.080
 Why?
Cohort Studies
2
2022
1452
0.070
 Why?
Prevalence
2
2020
971
0.070
 Why?
Intracranial Hemorrhages
1
2022
38
0.050
 Why?
Risk Factors
2
2022
3724
0.050
 Why?
Multiple Myeloma
1
2016
2998
0.050
 Why?
Cerebral Hemorrhage
1
2022
100
0.050
 Why?
Cranial Sinuses
1
2021
10
0.050
 Why?
Industry
1
2020
17
0.050
 Why?
Arthritis, Psoriatic
1
2020
9
0.040
 Why?
Spondylitis, Ankylosing
1
2020
9
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
88
0.040
 Why?
Endocrine System Diseases
1
2010
9
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
 Why?
Mortality
1
2020
96
0.040
 Why?
Colitis, Ulcerative
1
2020
56
0.040
 Why?
Arthritis, Rheumatoid
1
2020
106
0.040
 Why?
Maximum Tolerated Dose
1
2019
39
0.040
 Why?
Crohn Disease
1
2020
93
0.040
 Why?
Administration, Oral
1
2020
434
0.040
 Why?
Tertiary Care Centers
1
2019
76
0.040
 Why?
Registries
1
2022
563
0.040
 Why?
Disease Outbreaks
1
2020
120
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
70
0.040
 Why?
Hemorrhage
1
2020
197
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Skin Diseases
1
2010
112
0.040
 Why?
Gastrointestinal Diseases
1
2010
125
0.040
 Why?
Electronic Health Records
1
2021
220
0.040
 Why?
Drug Administration Schedule
1
2019
370
0.040
 Why?
Recovery of Function
1
2019
191
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
226
0.040
 Why?
Comorbidity
1
2019
623
0.040
 Why?
Patient Readmission
1
2019
227
0.040
 Why?
Double-Blind Method
1
2019
708
0.040
 Why?
Prognosis
1
2022
1978
0.030
 Why?
Fatal Outcome
1
2016
197
0.030
 Why?
Follow-Up Studies
1
2020
2242
0.030
 Why?
Risk Assessment
1
2019
1270
0.030
 Why?
Cardiovascular Diseases
1
2010
461
0.030
 Why?
Prospective Studies
1
2020
2378
0.030
 Why?
Cross-Sectional Studies
1
2019
1610
0.030
 Why?
DNA Primers
1
2002
206
0.020
 Why?
Infant
1
2020
3628
0.020
 Why?
Child, Preschool
1
2020
3942
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
405
0.020
 Why?
Transcription, Genetic
1
2002
361
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
188
0.020
 Why?
RNA, Messenger
1
2002
1089
0.020
 Why?
Child
1
2020
6906
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (151) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department